Monopar Therapeutics Inc (MNPR) Up 5.79% in Premarket Trading

Monopar Therapeutics Inc (MNPR) is up Wednesday morning, with the stock climbing 5.79% in pre-market trading to 1.28. MNPR's short-term technical score of 65 indicates that the stock has traded more bullishly over the last month than 65% of stocks on the market. In the Biotechnology industry, which ranks 85 out of 146 industries, Monopar Therapeutics Inc ranks higher than 74% of stocks. Monopar Therapeutics Inc has risen 236.11% over the past month, closing at $0.34 on January 31. During this period of time, the stock fell as low as $0.31 and as high as $1.73. MNPR has an average analyst recommendation of Strong Buy. The company has an average price target of $8.50.

MNPR has an Overall Score of 86. Find out what this means to you and get the rest of the rankings on MNPR!

See Full MNPR Report

Monopar Therapeutics Inc has a Long-Term Technical rank of 99. This means that trading over the last 200 trading days has placed the company in the upper half of stocks with 1% of the market scoring higher. In the Biotechnology industry which is number 47 by this metric, MNPR ranks better than 47% of stocks.

Important Dates for Investors in MNPR:

-Monopar Therapeutics Inc is set to release earnings on 2024-03-28. Over the last 12 months, the company has reported EPS of $-0.72. -We do not have a set dividend date for Monopar Therapeutics Inc at this time. Click Here To Get The Full Report on Monopar Therapeutics Inc (MNPR)